Plain-English translation of NCT05916339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This research trial is testing whether the most commonly prescribed ADHD medications—methylphenidate and amphetamine compounds—work well for children who have both autism spectrum disorder and ADHD. Right now, doctors don't have clear guidance on which medication works best for children with both conditions, so this study aims to fill that gap and help families make better treatment choices.
Children with autism often also have ADHD, but they may respond differently to ADHD medications than other children. Without clear recommendations, families and doctors struggle to find the right medication, which can lead to poor results and frustration. This study will help doctors understand which treatments actually work for this group.
You likely qualify if…
You likely don't qualify if…
You and your doctor will discuss which medication to start with—either methylphenidate or amphetamine—and your parent will get it from a regular pharmacy. Every two weeks, your parent will rate how well the medication is working using a simple form. If the first medication doesn't work well enough after a few weeks, you may move to a second stage where you try a different medication. Throughout the study, your parent will complete rating forms to help the doctors understand how the treatment is affecting your attention and behavior.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States